News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
748,942 Results
Type
Article (44169)
Company Profile (313)
Press Release (704440)
Multimedia
Podcasts (127)
Webinars (22)
Section
Business (211190)
Career Advice (2117)
Deals (36803)
Drug Delivery (141)
Drug Development (83531)
Employer Resources (176)
FDA (16901)
Job Trends (15530)
News (357773)
Policy (34150)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2640)
Accelerated approval (45)
Adcomms (28)
Allergies (174)
Alliances (51594)
ALS (204)
Alzheimer's disease (1787)
Antibody-drug conjugate (ADC) (440)
Approvals (17258)
Artificial intelligence (661)
Autoimmune disease (257)
Automation (53)
Bankruptcy (373)
Best Places to Work (11770)
BIOSECURE Act (21)
Biosimilars (223)
Biotechnology (188)
Bladder cancer (184)
Brain cancer (72)
Breast cancer (727)
Cancer (5721)
Cardiovascular disease (471)
Career advice (1800)
Career pathing (42)
CAR-T (321)
CDC (57)
Celiac Disease (2)
Cell therapy (860)
Cervical cancer (45)
Clinical research (72151)
Collaboration (2066)
Company closure (4)
Compensation (1339)
Complete response letters (85)
COVID-19 (2808)
CRISPR (109)
C-suite (1096)
Cystic fibrosis (155)
Data (7553)
Decentralized trials (3)
Denatured (38)
Depression (161)
Dermatology (73)
Diabetes (576)
Diagnostics (6980)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (317)
Drug pricing (217)
Drug shortages (34)
Duchenne muscular dystrophy (276)
Earnings (93107)
Editorial (67)
Employer branding (21)
Employer resources (155)
Events (121993)
Executive appointments (1090)
FDA (20548)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1694)
Gene editing (231)
Generative AI (57)
Gene therapy (704)
GLP-1 (1085)
Government (4861)
Grass and pollen (7)
Guidances (404)
Healthcare (19156)
HIV (77)
Huntington's disease (54)
IgA nephropathy (95)
Immunology and inflammation (293)
Immuno-oncology (88)
Indications (174)
Infectious disease (3141)
Inflammatory bowel disease (212)
Inflation Reduction Act (14)
Influenza (135)
Intellectual property (287)
Interviews (328)
IPO (16935)
IRA (57)
Job creations (4073)
Job search strategy (1502)
JPM (65)
Kidney cancer (18)
Labor market (96)
Layoffs (586)
Leadership (39)
Legal (8427)
Liver cancer (100)
Longevity (33)
Lung cancer (760)
Lymphoma (424)
Machine learning (60)
Management (60)
Manufacturing (1019)
MASH (185)
Medical device (13988)
Medtech (14081)
Mergers & acquisitions (21083)
Metabolic disorders (1491)
mRNA (205)
Multiple sclerosis (182)
NASH (18)
Neurodegenerative disease (402)
Neuropsychiatric disorders (105)
Neuroscience (3276)
Neurotech (1)
NextGen: Class of 2026 (6652)
Non-profit (4577)
Now hiring (75)
Obesity (703)
Opinion (310)
Ovarian cancer (208)
Pain (262)
Pancreatic cancer (288)
Parkinson's disease (353)
Partnered (34)
Patents (585)
Patient recruitment (641)
Peanut (64)
People (61537)
Pharmaceutical (85)
Pharmacy benefit managers (34)
Phase 1 (22392)
Phase 2 (31746)
Phase 3 (23767)
Pipeline (7913)
Policy (326)
Postmarket research (2658)
Preclinical (9553)
Press Release (68)
Prostate cancer (289)
Psychedelics (55)
Radiopharmaceuticals (325)
Rare diseases (1065)
Real estate (6316)
Recruiting (72)
Regulatory (26148)
Reports (56)
Research institute (2462)
Resumes & cover letters (364)
Rett syndrome (36)
RNA editing (22)
RSV (88)
Schizophrenia (182)
Series A (285)
Series B (210)
Service/supplier (11)
Sickle cell disease (112)
Special edition (25)
Spinal muscular atrophy (168)
Sponsored (48)
Startups (3784)
State (2)
Stomach cancer (19)
Supply chain (128)
Tariffs (99)
The Weekly (87)
Vaccines (1107)
Venture capital (105)
Weight loss (463)
Women's health (121)
Worklife (20)
Date
Today (181)
Last 7 days (735)
Last 30 days (2847)
Last 365 days (30752)
2026 (10522)
2025 (30680)
2024 (35764)
2023 (40630)
2022 (51801)
2021 (56333)
2020 (54797)
2019 (47409)
2018 (35776)
2017 (33138)
2016 (32664)
2015 (38620)
2014 (32518)
2013 (27633)
2012 (29735)
2011 (30487)
2010 (28500)
Location
Africa (805)
Alabama (91)
Alaska (7)
Arizona (348)
Arkansas (16)
Asia (42529)
Australia (6824)
California (12842)
Canada (3675)
China (1334)
Colorado (549)
Connecticut (554)
Delaware (393)
Europe (91467)
Florida (1921)
Georgia (410)
Hawaii (3)
Idaho (62)
Illinois (1040)
India (91)
Indiana (592)
Iowa (23)
Japan (527)
Kansas (130)
Kentucky (50)
Louisiana (41)
Maine (75)
Maryland (1542)
Massachusetts (9185)
Michigan (356)
Minnesota (699)
Mississippi (6)
Missouri (143)
Montana (34)
Nebraska (29)
Nevada (139)
New Hampshire (85)
New Jersey (3401)
New Mexico (29)
New York (3380)
North Carolina (1643)
North Dakota (8)
Northern California (6392)
Ohio (380)
Oklahoma (24)
Oregon (46)
Pennsylvania (2594)
Puerto Rico (28)
Rhode Island (50)
South America (1179)
South Carolina (86)
South Dakota (2)
Southern California (5056)
Tennessee (206)
Texas (2031)
United States (45500)
Utah (383)
Vermont (1)
Virginia (321)
Washington D.C. (80)
Washington State (1035)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
748,942 Results for "acumen pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
March 11, 2026
·
1 min read
Press Releases
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights
March 26, 2026
·
13 min read
Press Releases
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026
March 20, 2026
·
1 min read
Press Releases
Acumen Pharmaceuticals to Showcase Advances in Alzheimer’s Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
March 3, 2026
·
7 min read
Press Releases
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer’s Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
March 17, 2026
·
9 min read
Press Releases
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
March 16, 2026
·
8 min read
Press Releases
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference 2025
November 4, 2025
·
1 min read
Press Releases
Acumen Pharmaceuticals Reports Third Quarter 2025 Financial Results and Business Highlights
November 13, 2025
·
12 min read
Press Releases
Acumen Pharmaceuticals Appoints George Golumbeski, Ph.D., as Chairman of its Board of Directors
November 11, 2025
·
5 min read
Press Releases
Acumen Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 12, 2025
November 5, 2025
·
1 min read
1 of 74,895
Next
